# Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema

> **NCT00427986** · NA · TERMINATED · sponsor: **Glostrup University Hospital, Copenhagen** · enrollment: 1 (actual)

## Conditions studied

- Diabetic Macular Oedema

## Interventions

- **DRUG:** Galactose, intravenous

## Key facts

- **NCT ID:** NCT00427986
- **Lead sponsor:** Glostrup University Hospital, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** No sufficient increase in plasma osmolarity by galactose (one patient included)
- **Last updated:** 2007-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00427986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00427986, "Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00427986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*